CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 240 filers reported holding CONMED CORP in Q4 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $994,693 | -28.6% | 9,868 | -3.7% | 0.00% | -20.0% |
| Q2 2023 | $1,392,950 | -0.8% | 10,251 | -24.2% | 0.01% | 0.0% |
| Q1 2023 | $1,404,257 | -27.2% | 13,521 | -37.8% | 0.01% | +25.0% |
| Q4 2022 | $1,928,757 | +80.6% | 21,751 | +63.3% | 0.00% | -20.0% |
| Q3 2022 | $1,068,000 | -15.8% | 13,323 | +0.6% | 0.01% | -16.7% |
| Q2 2022 | $1,268,000 | -18.3% | 13,241 | +26.7% | 0.01% | -14.3% |
| Q1 2022 | $1,552,000 | +7.9% | 10,452 | +2.9% | 0.01% | +16.7% |
| Q4 2021 | $1,439,000 | +13.2% | 10,157 | +4.6% | 0.01% | 0.0% |
| Q3 2021 | $1,271,000 | +18.0% | 9,710 | +23.9% | 0.01% | +20.0% |
| Q2 2021 | $1,077,000 | -0.9% | 7,835 | -5.8% | 0.01% | 0.0% |
| Q1 2021 | $1,087,000 | +26.2% | 8,319 | +8.3% | 0.01% | +25.0% |
| Q4 2020 | $861,000 | +207.5% | 7,683 | +115.5% | 0.00% | +300.0% |
| Q3 2020 | $280,000 | +12.9% | 3,565 | +3.5% | 0.00% | 0.0% |
| Q2 2020 | $248,000 | – | 3,444 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 190,000 | $24,858,000 | 3.57% |
| Ranger Investment Management | 253,789 | $33,203,000 | 1.77% |
| EARNEST PARTNERS LLC | 1,603,130 | $209,737,000 | 1.28% |
| Penn Capital Management Company, LLC | 92,086 | $12,048,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,492,419 | $195,253,000 | 0.94% |
| MOODY ALDRICH PARTNERS LLC | 53,257 | $6,968,000 | 0.88% |
| Hood River Capital Management LLC | 215,384 | $28,179,000 | 0.87% |
| OAK RIDGE INVESTMENTS LLC | 71,880 | $9,404,000 | 0.83% |
| WAFRA INC. | 138,542 | $18,125,000 | 0.66% |
| EPIQ PARTNERS, LLC | 10,463 | $1,369,000 | 0.63% |